Data is not available at this time.
ProAssurance Corporation operates as a specialty insurer focused on professional liability, workers' compensation, and medical malpractice coverage. The company primarily serves healthcare providers, legal professionals, and other niche markets requiring tailored risk management solutions. Its revenue model hinges on underwriting premiums and investment income, with a disciplined approach to claims management. ProAssurance differentiates itself through deep industry expertise, long-standing client relationships, and a conservative underwriting philosophy that prioritizes profitability over market share expansion. The company operates in a highly competitive and regulated sector, where pricing discipline and claims accuracy are critical to maintaining margins. ProAssurance's market position is bolstered by its reputation for stability and reliability, though it faces pressure from larger diversified insurers and evolving regulatory landscapes.
ProAssurance reported revenue of $1.13 billion for FY 2024, with net income of $52.7 million, translating to diluted EPS of $1.03. Operating cash flow was negative at $10.7 million, reflecting challenges in premium collections or claims payouts. Capital expenditures were modest at $9.0 million, suggesting limited investment in growth initiatives. The company's profitability metrics indicate operational efficiency but highlight sensitivity to underwriting performance and investment yields.
The company's earnings power is constrained by its niche focus and reliance on underwriting discipline. With diluted EPS of $1.03, ProAssurance demonstrates modest earnings generation relative to its capital base. The negative operating cash flow raises questions about working capital management, though the absence of dividends suggests retained earnings are being prioritized for balance sheet strength or future growth opportunities.
ProAssurance maintains a conservative balance sheet with $54.9 million in cash and equivalents against $442.3 million in total debt. The debt level appears manageable given the company's revenue base, but the negative operating cash flow warrants monitoring. The lack of dividend payouts may reflect a cautious approach to capital allocation, possibly aimed at preserving liquidity or addressing claims volatility.
Growth trends appear muted, with no dividend payments in FY 2024, signaling a focus on internal capital retention. The company's niche market positioning limits rapid expansion but offers stability. Future growth may depend on underwriting margin improvements or strategic acquisitions, though the current financials suggest a cautious approach to capital deployment.
ProAssurance's valuation likely reflects its specialized market focus and mixed financial performance. Investors may price in expectations of steady but slow growth, given the company's conservative underwriting and lack of dividend yield. The negative operating cash flow could weigh on market sentiment, though the manageable debt levels provide some balance sheet support.
ProAssurance's strategic advantages lie in its deep industry expertise and disciplined underwriting. However, the outlook is tempered by operational challenges, including negative cash flow and competitive pressures. The company's ability to maintain profitability in a hard insurance market will be critical. Long-term success may hinge on leveraging its niche strengths while addressing efficiency and cash flow concerns.
Company filings (10-K), CIK 0001127703
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |